Tag: scopio

[Scopio in PR Newswire] Scopio Labs launches world’s first digital application for bone marrow aspirate imaging and review 

TEL AVIV, Israel, Sept. 8, 2022 /PRNewswire/ — Scopio Labs, developer of Full-Field Cell Morphology™ imaging and AI-powered analysis platforms to support laboratory professionals in the detection of cancers, anemia, infections, and other blood-related diseases, announced today the launch of the Full-Field Bone Marrow Aspirate™ (FF-BMA) Application. This platform is the first to enable a complete digital workflow for bone marrow aspirate scanning and analysis. Scopio’s high resolution Full-Field imaging and AI-driven Decision Support System brings a much-desired digital transformation to hematopathology. With embedded remote analysis capabilities over a secure hospital network, the application provides the ability to review the aspirate from any location, in the lab or from remote sites, eliminating the need for a manual microscope to perform a BMA review. Read...

Read More

[Scopio in PR Newswire] Beckman Coulter and Scopio Labs Partner to Accelerate Adoption of Hematology Digital Cell Morphology Platform

BREA, Calif., July 20, 2022 /PRNewswire/ — Beckman Coulter, a global leader in clinical diagnostics, and Scopio Labs, a medtech company that develops AI-powered workflow solutions, announced today a worldwide partnership to accelerate adoption of Scopio’s next generation peripheral blood smear platforms. Scopio’s technology employs Full-Field imaging and AI decision support to truly eliminate manual microscopy, while providing laboratory professionals and clinicians a true workflow benefit. With simple to use remote viewing, the Scopio solutions simplify lab operations and improve workflow in a distributed network. High resolution full-field images can now be shared in real time over a secure hospital network – no more slides being shipped between locations. Read...

Read More

[Scopio in AIMed] Replacing microscopes with digitization

Scopio Labs, a medtech company that develops AI-powered diagnostic platforms for earlier and more accurate detection of cancers, infections, and other diseases, has announced that its ground-breaking X100HT device with Peripheral Blood Smear (PBS) Application has received US FDA 510(k) clearance. Read...

Read More

Latest from Twitter